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SUMMARY: The case of a patient with gastric adenocarcinoma with indication for gastrectomy is reported.
The surgery took place without complications. A palliative, subtotal gastrectomy was performed after para-aortic lymph nodes compromised by
neoplasm were found, which was confirmed by pathological exam of frozen sections carried out during the intervention. At the end of the gastroentero-
anastomosis procedure, the patient began to show intense bradycardia: 38 beats per minute (bpm), arterial hypotension, changes in the electrocardiogra-
m’s waveform (upper unlevelling  of segment ST), and cardiac arrest. Resuscitation maneuvers were performed with temporary success. Subsequently,
the patient had another circulatory breakdown and again was recovered. Finally, the third cardiac arrest proved to be irreversible, and the intra-operative
death occurred.
Necropsy showed massive pulmonary embolism. The medical literature has recommended heparinization of patients, in an attempt to avoid pul-
monary thromboembolism following major surgical interventions. However, in the present case, heparinization would have been insufficient to prevent
death. This case indicates that it is necessary to develop preoperative propedeutics for diagnosing the presence of venous thrombi with potential to migra-
te, causing pulmonary thromboembolism (PTE). If such thrombi could be detected, preventative measures, such as filter installation in the Cava vein could
be undertaken.
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The occurrence of thromboem-
bolic phenomena in the periopera-
tive period has concerned the med-
ical establishment, especially sur-
geons, during the past few years. The
finding of massive pulmonary
embolism in necropsies occurs at a
very high rate. In the United States,
pulmonary thromboembolism (PTE)
is found in 28% of necropsies, IS
fatal for 0.5 to 1 in every one thou-
sand inhabitants per annum, and
responds for 300,000 to 600,000
hospitalizations per year 1,2.
As early as 1856, Rudolf Virchow
defined vascular thrombosis and its
triad—alteration of vessels, alteration
of blood elements, and alteration of
blood flow—and their relation with
pulmonary embolism. From his stud-
ies, the bases for the thrombosis
treatment were established. In 1894,
Von Strauch was the first to describe
thrombosis following surgery3.
The prophylactic principles were
initially proposed in 1945 by Dahl-
Inversen (4), basically involving pre-
cocious mobilization. However, the
use of prophylaxis was not widely
used until the 1970’s, when different
prophylactic methods were devel-
oped and many randomized trials
proving the efficacy of PTE prophy-
laxis were performed5.
CLINICAL CASE
The patient was 74 years old,
male, white, and was admitted into the
hospital complaining about burning
epigastric pain for the previous 8
months that improved with the use of
antacids. He mentioned progressive
postprandial cramming of the stom-
ach in the period, accompanied by
nausea. In the week preceding his
admission, he had had postprandial
vomiting.
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He was a cigarette addict, having
consumed five cigarettes a day for
40 years. He had lost 8 kg and his
usual weight was 74 kg. As a surgi-
cal antecedent, he mentioned having
undergone an appendectomy 48
years ago.
At the physical exam, he was in
general good condition, ruddy, hydrat-
ed, thin, with a body mass index
(BMI) of 21.4 kg/m2, without cervical
or inguinal adenomegaly. His weight
was 65.8 kg, with a 130-mmHg sys-
tolic blood pressure and 80 mmHg
diastolic, a respiratory rate of 18
inhalations per minute, 88 beats per
minute (bpm) peripheral pulse, and
36.2 °C axillar temperature.
A thorax exam revealed lungs with
normal-expansiveness, the presence
of a bilateral vesicular murmur, and
the absence of adventitious noises; the
heart showed normal ictus and steady
auscultation. The abdomen was level,
slightly hollowed, there was a
MacBurney scar in the right iliac
region, palpation was painless, and
there was no perception of a mass; the
liver and spleen were impalpable, and
upon auscultation only normal
hydroaerial noises were heard.
Laboratory results were: sodium
(Na) = 138 mEq/l, potassium (K) =
4.6 mEq/l, urea = 46 mg/dl, creatinine
= 0.9 mg/dl, hemoglobin (Hg) = 10.6
g/dl, hematocrit (Ht) = 32.6%, medi-
um corpuscular volume = 70 mm3,
leukocytes = 8,800, 4% of which
being rods, 73% segmented cells, and
13% lymphocytes; total bilirubins
were 0.4 mg/dl, with 0.2 mg/dl direct
bilirubin, oxaloacetic transaminase =
12 mg/dl, glutamic-pyruvic transami-
nase = 25 mg/dl, prothrombine activi-
ty 75% FROM normal, and INR
(International Normalized Ratio) =
1.2, ATPT (Activated Thromboplastin
Time) = 21.1 seconds (Ratio = 0.88),
thrombin time = 12.3 seconds (Ratio
= 0.87), total serum proteins = 7 g/dl,
with 4 g/dl albumin, carcinoembrion-
ic antigen > 10,000 hg/ml and CA
19.9 > 222 U/ml.
The patient received nutritional
replacement by naso-enteral tube,
positioned with the help of per oral
endoscopy, thus recovering 1,200 g.
The contrasted radiological exam of
the esophagus, stomach, and duode-
num showed an esophagus of usual
topography and normal size, contours,
and emptying. The esophagogastric
transition was without change. The
antro-pyloric region displayed a large
filling failure  that prevented normal
gastric emptying. The diagnosis was:
“Proliferative and infiltrative neopla-
sia of the stomach”.
The per-oral endoscopic exam
revealed mild erosive esophagitis and
hiatal hernia with a 3-cm slide, and an
ulcerated lesion in the pre-pyloric
region of the stomach. The lesion had
infiltrative borders, was vegetating
and friable, and easily bled at a touch
of the device. The lesion spread
through the great curvature, and
through the anterior and posterior wall
of the pre-pyloric antrum, not allow-
ing the passage of the device.
Diagnosis: “Borrmann III-type gastric
ulcer lesion, stenosis-inducing, locat-
ed in the gastric antrum”. The biopsy
obtained in the endoscopic exam
showed little differentiated tubular
gastric antrum adenocarcinoma.
The radiographic thorax exam
result was normal. The abdomen’s
ultrasonographic exam showed nor-
mal liver, gallbladder, biliary tract,
pancreas, and spleen.
The preoperative clinical evalua-
tion showed the patient fitting the
classification of the ASA I risk of the
American Society of Anesthe-
siologists.
During the surgery, the presence
of para-aortic lymph nodes metastases
and peritoneal implantations in the
small omentum and liver were con-
firmed by the pathological exam of
frozen sections. Thus the treatment
was considered palliative. The patient
underwent a subtotal gastrectomy
with Billroth II-type, pre-cholic,
anisoperistaltic, two-plane reconstruc-
tion.
At the end of the procedure, when
the last plane of the gastrojejunal
anastomosis was being done, the end
of the surgery was accelerated
because of several cardiovascular
changes, while adhering to the best
technical norms, with a review of the
cavity before closing, which was
made through continuous suture in
aponeurosis in simple skin stitches.
The surgery took approximately 3
hours and 40 minutes, and anesthesia
5 hours and 10 minutes, with infusion
of 4000-ml crystalloids, 40-ml albu-
min at 20%, and 3 units erythrocyte
concentrate. The laboratory exams
requested during surgery and before
the incident showed: Hg = 7.8 g/dl, Ht
= 26%, Na = 131 mEq/l and K = 4.8
mEq/l. Despite the ASA I pre-opera-
tive evaluation, the patient progressed
poorly. 
The first alteration—intense
bradycardia (cardiac rate < 15 bpm)
that responded well to atropine—
occurred during the infusion of the
second unit of globule concentrate,
following an apparently stable and
normal clinical status. After a few
minutes, his cardiac rate dropped
again (15 to 20 bpm), with marked
hypotension, a drop in O2 saturation
to 80%, hepatic congestion, and
ischemia of the intestinal loops veri-
fied in the operating field, followed by
cardiac arrest. Resuscitation was
begun with external cardiac massage
and administration of adrenaline,
resulting in ventricular fibrillation
which reverted with electrocardiover-
sion, allowing completion of the sur-
gery. However, while still on the oper-
ating table, the patient once again pre-
sented bradycardia, hypotension and
ventricular fibrillation, and was again
cardioverted with success. At this
moment, changes in the waveform on
the cardiac monitor showed upper
unlevelling of the ST segment. The
patient developed a new intense
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bradycardia that did not respond to the
infusion of dopamine and sodium
bicarbonate, nor was there either an
oximetric or cardiovascular response
following external massage and car-
dioversion. After 1 hour and a half of
resuscitation, and after an additional
cardioversion, it was admitted that the
condition was irreversible, and the
patient was pronounced dead.
The pathological exam of the sur-
gical material showed a 5.1–cm long
Borrmann III ulceroinfiltrative neo-
plasm, located in the great curvature
of the gastric antrum, of A moderate-
ly differentiated tubular adenocarci-
noma histological type, infiltrating
even fat from the great curvature; the
resection margins were free from neo-
plastic compromise; vascular and
lymphatic invasion was present, per-
ineural invasion was not detected;
there was presence of lymph node
metastases (10 in 12 lymph nodes
researched); presence of metastasis
for the designated material as serosa
of the hepatic hilus; moderate chronic
gastritis in pyloric mucous with com-
plete intestinal metaplasia.
The necropsy performed to check
the cause of death revealed the pres-
ence of massive, bilateral pulmonary
thromboembolism and metastases in
pulmonary hilus, mesenteric and peri-
pancreatic lymph nodes.
The final staging was T3, N2, M1,
that is: penetration in the gastric wall:
T3, regional lymph node situation: N2
and presence of distant metastasis:
M1, which configured stage IV by the
UICC TNM classification.
DISCUSSION
The described case presents some
particularities that should be stressed.
Usually, thromboembolic phenomena
related to surgery occur after the third
day following the operation when the
patient starts to walk, and up to 30
days after the procedure6. In this case,
it should be emphasized that the pul-
monary embolism took place during
surgery. It is evident that the patient
had already had thrombosis. That this
situation has rarely been reported is
noteworthy.
Our experience emphasizes that
risk factors for deep venous thrombo-
sis should always be researched prior
to surgery. According to Hirsh’s7 and
the European Consensus Group of
Thromboembolic Risk Factors’8 clas-
sification, they are:
• age (40 years or older), 
• varices in the lower limbs,
•  previous deep venous thrombo-
sis (DVT) or PTE,
•  major surgery, 
• NEOPLASIA, 
• obesity (BMI > 30), 
• previous myocardial acute
infarction, 
• congestive cardiac failure, 
• use of estrogen over the last 6
weeks, and
•  serious infectious status (local-
ized or sepses).
According to the above classifica-
tion, a patient at low risk is one pre-
senting 1 risk factor; at moderate risk
when presenting 2 to 5 factors, and at
high risk when presenting more than 5
factors.
This patient was considered at
moderate risk for DVT, as he present-
ed 3 factors: age, major surgery, and
neoplasia. In this case, the malignant
disease was probably a factor of spe-
cial relevance to the fatal DVT.
By itself, the neoplasia may inter-
fere with the homeostatic balance.
The possible contributing causes
towards development of thrombosis in
the cancer include the capacity of the
tumor cells and their products to inter-
act with the platelets and the fibri-
nolytic system, as well as with the
endothelial and macrophage cells. The
release of cytokines, the acute phase
reactions, and neovascularization may
contribute to activation of the coagu-
lation cascade. Finally, a direct effect
of coagulation activation has been
proposed, based on pharmacological
studies in genetically modified rats
with tumor cells 9. GASTRIC adeno-
carcinoma by itself can promote
embolization of the tumor nests in the
pulmonary vasculature and result in
death, as described by Cheung et al .10,
but this was not what was found in the
necropsy in the present case.
Nevertheless, the high incidence
of DVT in some patients may occur
due to the association with other fac-
tors such as old age, different types of
surgery, operative position, and patients
bedridden for long periods 11.
Studies show that 25% of people
over 40 years old undergoing general
medium-size surgeries lasting more
than 45 minutes, without the use of pro-
phylactics develop DVT 12, 13, 14.
In colon-rectal surgery, for
instance, it has been observed that the
incidence of fatal pulmonary
embolism is 3%, with rectal surgeries
having greater incidence of throm-
boembolic phenomena 15, 16.
Although considered AT moder-
ate risk, the fact is that this patient
was probably already a bearer of
deep venous thrombosis in the preop-
erative period which, under surgical
and anesthetic stress, massively
migrated to the pulmonary veins,
causing his death. One should ponder
whether we should routinely apply
other diagnostic methods, such as
Doppler’S, even in patients at moder-
ate risk and in case of having a
thrombosis diagnosis, to install, prior
to the gastrectomy, such devices as
filters on the lower Cava vein, thus
preventing the migration of thrombi
to the pulmonary arteries.
Nowadays, there is a wide variety
of prophylactic methods, both
mechanical and medicinal, but the
prophylaxis issue, when and how to
adopt it, as well as the definition of
risk groups for DVT, are considerably
varied among the different centers.
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The mechanical prophylactic
methods involve early walking, pas-
sive plantar-dorsal flexion of the feet,
elastic compression stockings, elec-
tric stimulation of the calves and
intermittent pneumatic compression
(IPC). In our service, we usually use
elastic stockings and encourage early
walking and passive exercises. The
electric stimulation of the calves is
seldom used in our service, and it is
indicated only to comatose or anes-
thetized patients. IPC is a good
method, but it is not available in most
of our hospitals.
The medicinal options for prophy-
laxis are: vitamin K antagonists (oral
anticoagulants, which are used pri-
marily in the post-operative period of
orthopedic surgeries), heparin in low
doses, low molecular weight heparins
(LMWH) dextran, dihydroergota-
mine, and acetylsalicylic acid. The
latter three are used less often: dex-
tran, due to the risk of anaphylactic
reactions (17), dihydroergotamine
because it has been related, in some
studies, to the occurrence of arterial
failures and myocardial infarction
(18), and acetylsalicylic acid because
it has not shown to be efficient by
itself (19).
However, the use of LMWH IN
DVT prophylaxis was only approved
for use in the United States in 1986,
following the NIH (National Institute
of Health) Consensus Conference 1.
It is known that the association of
prophylactic methods, especially
LMWH, with the use of elastic com-
pression stockings, additionally
reduces the incidence of DVT 20.
Comparisons between LMWH and
heparin in low doses have shown a
similar efficiency in preventing DVT,
but the LMWHs have some advan-
tages: the administration (once a day)
is better accepted by the patient, hem-
orrhagic complications are less fre-
quent and there is no need for labora-
tory control 21,22,23. Another study
shows that the incidence of DVT in
general surgery is 7.6% when non-
fractionated heparin is used, and 3.8%
with the use of LMWH 24.
Although the current trend is
towards the use of LMWHs as med-
ical prophylaxis and, if possible, asso-
ciating it with some mechanical
method 25, the fact is that in the cur-
rent case the use of prophylaxis would
probably not have prevented the fatal
outcome. In contrast to the normal
occurrence, thrombosis did not devel-
op following surgery, but was already
present in the great veins of the
patient, and it migrated at the end of
the surgery to the pulmonary arteries,
causing death. Only a pre-operative
diagnosis and, thus, the consequent
installation of an intra-caval filter,
could have prevented PTE.
As for diagnosis, Doppler is the
image exam of choice for most
patients 26. However, together with
venography and scintigraphy by
radioisotopes, new methods are being
used, such as pulmonary angiography
by Magnetic Nuclear Resonance,
which is a noninvasive procedure
with a sensitivity FROM 75% to
100% AND specificity FROM 42%
to 90% 27.
It is interesting to note that little
attention has been given to the deep
venous thrombosis of the upper limbs.
Possibly many of these thromboses
will go unnoticed since symptoms are
much more modest, compared to what
happens in thromboses of the lower
limb veins. However, the severity of
embolism when the thromboses origi-
nate in the veins of the upper limb is
similar to that observed when they
originate in the veins of the lower
limbs38.
The case reported here shows that
one should always research risk factors
for DVT, pay attention to the thrombo-
genic trend of neoplasias, and try to
provide the patient with some prophy-
lactic method, since the DVT and PTE
incidences are not minor, and their
consequences are very serious.
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RESUMO
BRESCIANI, C. e col.  -  Trombo-
embolismo pulmonar fatal no intra-
operatório de gastrectomia por ade-
nocarcinoma gástrico: relato de
caso.  Rev. Hosp. Clín. Fac. Med.
S. Paulo 54(4): 115 - 120,1999.
Relata-se um caso de paciente
com adenocarcinoma gástrico com
indicação de gastrectomia.
O ato operatório transcorreu sem
anormalidades. Foi realizada gastrec-
tomia subtotal paliativa, pois encon-
trou-se linfonodos para-aórticos com-
prometidos pela neoplasia, confirma-
do por exame anátomo-patológico de
congelação realizado no decorrer da
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